General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0WWBVZ
ADC Name
BC3195
Synonyms
BC-3195; BC 3195; BC3195
   Click to Show/Hide
Organization
Wuxi Biocity Biopharmaceutics Co., Ltd.
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Solid tumor
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
Undisclosed
Antigen Name
Cadherin-3 (CDH3)
 Antigen Info 
Payload Name
Monomethyl auristatin E
 Payload Info 
Therapeutic Target
Microtubule (MT)
 Target Info 
Conjugate Type
Undisclosed